Abstract

Results A total of 401 patients with a history of hypersensitivity reaction to RCM and were premedicated at re-exposure to RCM. Male was 177 (44.1%) and mean age was 55.83i¾11.92 years. Most common hypersensitivity symptom was urticaria (259, 64.6%), followed by itching (36.7%), rash (21.4%) and angioedema (13.2%). Hypotension was reported in 9 (2.2%) and syncope 5 (1.2%). Systemic steroid was prescribed in 143 patients (35.4%). After premedication, 139 patients (77.7%) had no hypersensitivity reactions to re-exposed RCM. Incidence of symptom after premedication such as uriticaria (12.4%), itching (5.6%), rash (5.1%), angioedema (2.2%) were significantly decreased compared with previous incidence (P 0.05) Conclusion The use of corticosteroid or antihistamine before administration of RCM may diminish the overall prevalence of reactions. Randomized controlled studies of the effects of pretreatment in patients with hypersensitivity reaction to RCM were needed.

Highlights

  • For patients with a known history of hypersensitivity reactions to radiocontrast media (RCM), premedication with antihistamines and corticosteroids before receiving RCM is recommended

  • Incidence of symptom after premedication such as uriticaria (12.4%), itching (5.6%), rash (5.1%), angioedema (2.2%) were significantly decreased compared with previous incidence (P

  • We investigate the effectiveness of premedication for hypersensitivity reactions to radiocontrast media (RCM) in one tertiary hospital

Read more

Summary

Introduction

For patients with a known history of hypersensitivity reactions to radiocontrast media (RCM), premedication with antihistamines and corticosteroids before receiving RCM is recommended. It has been shown that such premedication decreases the frequency of mild and aggregate allergic like reactions. Premedication does not prevent all subsequent reactions. 139 patients (77.7%) had no hypersensitivity reactions to re-exposed RCM. Incidence of symptom after premedication such as uriticaria (12.4%), itching (5.6%), rash (5.1%), angioedema (2.2%) were significantly decreased compared with previous incidence (P0.05)

Objectives
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call